Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Darcy

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
Journal of Cellular Physiology|May 1, 1995
Hydrocortisone and progesterone regulation of the proliferation, morphogenesis, and functional differentiation of normal rat mammary epithelial cells in three dimensional primary cultureK M Darcy, S F Shoemaker, P P Lee, et al.
Journal of Cancer|January 8, 2014
Current approaches and challenges in managing and monitoring treatment response in ovarian cancerCharlotte S Marcus, G Larry Maxwell, Kathleen M Darcy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology GroupMichael A Bookman, Kathleen M Darcy, Daniel Clarke-Pearson, et al.
Military Medicine|March 27, 2025
Management of Endometrial Cancer Precursors in the Military Health System: A Survey-Based StudyZachary A Kopelman, Stuart S Winkler, Emily R Penick, et al.
British Journal of Plastic Surgery|August 6, 1999
The use of the latissimus dorsi musculocutaneous flap for immediate correction of the deformity resulting from breast conservation surgeryC C Kat, C M Darcy, J M O'Donoghue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group StudyLaura Havrilesky, kathleen M Darcy, Hasnah Hamdan, et al.
Biomedicines|July 2, 2025
RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. <i>Biomedicines</i> 2020, <i>8</i>, 73Ana Paucarmayta, Hannah Taitz, Latoya McGlorthan, et al.
Biomedicines|April 5, 2020
Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In VitroAna Paucarmayta, Hannah Taitz, Latoya McGlorthan, et al.
British Journal of Plastic Surgery|May 18, 2004
A non-animal facial model for teaching local flaps to traineesS H Liew, J McPhail, J D Morton, et al.
Translational Cancer Research|February 4, 2022
TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological typesAna Paucarmayta, Hannah Taitz, Yovanni Casablanca, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Journal of Cellular Physiology|May 1, 1995
Hydrocortisone and progesterone regulation of the proliferation, morphogenesis, and functional differentiation of normal rat mammary epithelial cells in three dimensional primary cultureK M Darcy, S F Shoemaker, P P Lee, et al.
Journal of Cancer|January 8, 2014
Current approaches and challenges in managing and monitoring treatment response in ovarian cancerCharlotte S Marcus, G Larry Maxwell, Kathleen M Darcy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology GroupMichael A Bookman, Kathleen M Darcy, Daniel Clarke-Pearson, et al.
Military Medicine|March 27, 2025
Management of Endometrial Cancer Precursors in the Military Health System: A Survey-Based StudyZachary A Kopelman, Stuart S Winkler, Emily R Penick, et al.
British Journal of Plastic Surgery|August 6, 1999
The use of the latissimus dorsi musculocutaneous flap for immediate correction of the deformity resulting from breast conservation surgeryC C Kat, C M Darcy, J M O'Donoghue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group StudyLaura Havrilesky, kathleen M Darcy, Hasnah Hamdan, et al.
Biomedicines|July 2, 2025
RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. <i>Biomedicines</i> 2020, <i>8</i>, 73Ana Paucarmayta, Hannah Taitz, Latoya McGlorthan, et al.
Biomedicines|April 5, 2020
Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In VitroAna Paucarmayta, Hannah Taitz, Latoya McGlorthan, et al.
British Journal of Plastic Surgery|May 18, 2004
A non-animal facial model for teaching local flaps to traineesS H Liew, J McPhail, J D Morton, et al.
Translational Cancer Research|February 4, 2022
TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological typesAna Paucarmayta, Hannah Taitz, Yovanni Casablanca, et al.
Pageof 23